Thrombolytic therapy in acute ischaemic stroke: The jury needs more evidence

Medical Journal of Australia

Volumn 166, Issue 8, 1997, Pages 419-422

  Hankey, Graeme J ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; STROKE;

EID: 0030980081     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1997.tb123193.x     Document Type: Article

References (27)

1. FDA approves t-PA for stroke Lancet 1996: 347: 1822.
2. Fibrinolytic Therapy Trialists' (FIT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-322.
3. Hommel M, Boissel JP, Kornu C, for the MAST study group. Termination of trial of streptokinase in severe ischaemic stroke [letter]. Lancet 1995; 345: 57.
4. The Multicenter Acute Stroke Trial - Europe Study Group. Thrombolytic therapy with streptokinase in acute ischaemic stroke. N Engl J Med 1996; 335: 145-150.
5. Donnan GA, Davis SM, Chambers BR, et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995: 345: 578-579.
6. Donnan GA, Davis SM, Chambers BR, et al. for the Australian Streptokinase (ASK) Trial Study Group. Streptokinase for acute ischaemic stroke with relation to time of administration. JAMA 1996; 276: 961-966.
7. Candelise L, Aritzo E, Ciccone A, et al. for the Multicenter Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-1514.
8. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995; 333: 1581-1587.
10. Collen D, Lijnen HR. Basic and clinical aspects of fibrinoiysis and thrombolysis. Blood 1991; 78: 3114-3124.
11. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250, 310-318.
12. Warlow CP, Dennis MS, van Gijn J, et al. Stroke. A practical guide to management. Oxford: Blackwell Science, 1996.
13. Cabanes L, Mas JL, Cohen A, et al. Atrial septal aneurysm and patent foramen ovate as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transoesophageal echocardiography. Stroke 1993; 24: 1865-1873.
14. Hart RG. Cardiogenic embolism to the brain. Lancet 1992; 339: 589-594.
15. Amarenco P, Duyckaerts C, Tzourio C, et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992; 326: 221-225.
16. Fisher CM. Occlusion of the internal carotid artery. Arch Neurol Psychiatr 1951; 65: 346-377.
17. Lhermitte F, Gautier JC, Derouesne C. Nature of occlusions of the middle cerebral artery. Neurology 1970; 20: 82-88.
18. Koudstaal PJ, Stibbe J, Vermeulen M. Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ 1988; 297: 1571-1574.
19. WardlawJM, Yamaguchi T, del Zoppo G, Hacke W. Thrombolysis in acute ischaemic stroke. In: Warlow C, van Gijn J, Sandercock P, editors. Acute stroke module, Cochrane database of systematic reviews. London: BMJ Publishing, 1995.
20. Tognoni G, Roncaglioni MC. Dissent: an alternative interpretation of MAST-I. Lancet 1995; 346: 1515.
21. Horton. MAST-I: agreeing to disagree [editorial]. Lancet 1995; 346: 1504.
22. Wardlaw JM, Yamaguchi T, del Zoppo G, Hacke W. The efficacy and safety of thrombolytic therapy in acute ischaemic stroke: a systematic review of the randomised trials comparing thrombolysis with control. In: Warlow C, van Gijn J, Sandercock P, editors. Stroke module. Cochrane database of systematic reviews [database on disk and CD-ROM]. Oxford: Update Software, 1996; issue 3 (updated 6Sep1996).
23. Hommel M, Cornu C, Jaillard Serradj A, on behalf of the TAS-PP Group. Thrombolysis in acute stroke-pooling project (TAS-PP). Cerebrovasc Dis 1996; 6 Suppl 2:25.
24. The NIH t-PA Stroke Study Investigators. Predictors of symptomatic intracranial haemorrhage in stroke patients treated with t-PA. Cerebrovasc Dis 1996; 6 Suppl 2:26.
25. Donnan GA, Davis SM, Gerraty RP, et al. Australian Urokinase Stroke Trial (AUST). Cerebrovasc Dis 1996; 6 Suppl 2: 25.
26. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet 1982; 1: 328- 331.
27. Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that rnimic stroke in the emergency department. Arch Neurol 1995; 52: 1119-1122.